Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies

被引:236
作者
Deng, Yan [1 ,2 ]
Wang, Chi Chiu [1 ]
Choy, Kwong Wai [1 ,2 ]
Du, Quan [3 ]
Chen, Jiao [1 ]
Wang, Qin [4 ]
Li, Lu [1 ]
Chung, Tony Kwok Hung [1 ]
Tang, Tao [1 ,2 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China
[3] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China
[4] Linyi City Peoples Hosp, Div Med, Dist Nursing Off, Linyi, Peoples R China
关键词
RNA interference; Gene-silencing; RNAi delivery; Therapeutics; CATIONIC LIPOSOME REAGENT; LIPID-LIKE MATERIALS; DOUBLE-STRANDED-RNA; SIRNA DELIVERY; IN-VITRO; HEPATITIS-C; MULTIDRUG-RESISTANCE; NONVIRAL DELIVERY; DRUG-DELIVERY; CANCER-CELLS;
D O I
10.1016/j.gene.2013.12.019
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
During recent decades there have been remarkable advances in biology, in which one of the most important discoveries is RNA interference (RNAi). RNAi is a specific post-transcriptional regulatory pathway that can result in silencing gene functions. Efforts have been done to translate this new discovery into clinical applications for disease treatment. However, technical difficulties restrict the development of RNAi, including stability, off-target effects, immunostimulation and delivery problems. Researchers have attempted to surmount these barriers and improve the bioavailability and safety of RNAi-based therapeutics by optimizing the chemistry and structure of these molecules. This paper aimed to describe the principles of RNA interference, review the therapeutic potential in various diseases and discuss the new strategies for in vivo delivery of RNAi to overcome the challenges. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:217 / 227
页数:11
相关论文
共 130 条
[11]   GnT-V, macrophage and cancer metastasis: A common link [J].
Chakraborty, AK ;
Pawelek, JM .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (04) :365-373
[12]   Corneal Neovascularization: An Anti-VEGF Therapy Review [J].
Chang, Jin-Hong ;
Garg, Nitin K. ;
Lunde, Elisa ;
Han, Kyu-Yeon ;
Jain, Sandeep ;
Azar, Dimitri T. .
SURVEY OF OPHTHALMOLOGY, 2012, 57 (05) :415-429
[13]   Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review [J].
Chaturvedi, Kiran ;
Ganguly, Kuntal ;
Kulkarni, Anandrao R. ;
Kulkarni, Venkatarao H. ;
Nadagouda, Mallikarjuna N. ;
Rudzinski, Walter E. ;
Aminabhavi, Tejraj M. .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (11) :1455-1468
[14]   Potential clinical applications of siRNA technique: benefits and limitations [J].
Chen, Shao-Hua ;
Zhaori, Getu .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (02) :221-232
[15]   Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer [J].
Chen, Yunching ;
Bathula, Surendar Reddy ;
Li, Jun ;
Huang, Leaf .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (29) :22639-22650
[16]   Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept [J].
Chong, Rosalind H. E. ;
Gonzalez-Gonzalez, Emilio ;
Lara, Maria F. ;
Speaker, Tycho J. ;
Contag, Christopher H. ;
Kaspar, Roger L. ;
Coulman, Sion A. ;
Hargest, Rachel ;
Birchall, James C. .
JOURNAL OF CONTROLLED RELEASE, 2013, 166 (03) :211-219
[17]   Viral vector-mediated RNA interference [J].
Couto, Linda B. ;
High, Katherine A. .
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) :534-542
[18]   RNAi-based therapeutic strategies for metabolic disease [J].
Czech, Michael P. ;
Aouadi, Myriam ;
Tesz, Gregory J. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (08) :473-484
[19]   RNAi-based nanomedicines for targeted personalized therapy [J].
Daka, Ala ;
Peer, Dan .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (13) :1508-1521
[20]   Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications [J].
Dalby, B ;
Cates, S ;
Harris, A ;
Ohki, EC ;
Tilkins, ML ;
Price, PJ ;
Ciccarone, VC .
METHODS, 2004, 33 (02) :95-103